• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Poll Finds U.S. CRA Turnover Rate Fell to 21 Percent in November

Poll Finds U.S. CRA Turnover Rate Fell to 21 Percent in November

March 1, 2021

The rate of CRA turnover at U.S. CROs hit a new six-year low in November, declining to more than 21 percent, according to a newly released poll of 15 CROs.

CRA turnover fell by more than 5 percentage points to 24.3 percent in 2019, down from 29.4 percent in 2018, while foreign CROs saw an increase in turnover rate to 20.3 percent in 2019, continuing a three-year upward trend.

Both the poll and the turnover rates are included in consulting firm BDO USA’s 2020/2021 CRO Insights Report, a summary of the firm’s annual compensation survey that collects workforce data for 268 positions in the U.S. and 55 foreign countries.

Despite the improvement in the U.S. turnover rate, BDO said it was still a surprise and higher than expected because many believed the pandemic, and its effect on the job market, would result in more employees staying put. “However, this has not been the case,” the firm said, describing CROs’ human resources and management as “incredulous at the level of turnover.”

CROs have been unsuccessful in increasing compensation for jobs with the highest turnover and have not changed their compensation levels in a meaningful way for the past decade, BDO says. The firm found clinical monitoring managers saw a 1.8 percent annual increase in base salary between 2010 and 2020, and a 2.1 increase in total cash compensation. Clinical monitoring leads or specialists received a 2.4 percent increase in salary and a 2.2 percent increase in compensation over the same time frame. Level I, II and III CRA professionals received salary increases of 2.1, 1.7 and 2.2 percent, respectively, and compensation increases of 2.0, 1.6 and 2.1 percent, respectively, between 2010 and 2020.

Read the report here: https://bit.ly/3r5Xfic.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing